Cargando…
Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
Many epidemiological studies have shown that the incidence of immune thrombocytopenia (ITP) increases after age 60 years and peaks in patients over age 80 years. Therefore, ITP is a concern for physicians taking care of older patients, especially regarding its diagnosis and management. The diagnosti...
Autores principales: | Crickx, Etienne, Mahévas, Matthieu, Michel, Marc, Godeau, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885884/ https://www.ncbi.nlm.nih.gov/pubmed/36726813 http://dx.doi.org/10.2147/CIA.S369574 |
Ejemplares similares
-
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
por: Moulis, Guillaume, et al.
Publicado: (2022) -
Long-term complications of splenectomy in adult immune thrombocytopenia
por: Thai, Lan-Huong, et al.
Publicado: (2016) -
Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase IIb trial
por: Mahévas, Matthieu, et al.
Publicado: (2020) -
Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia
por: Crickx, Etienne, et al.
Publicado: (2021) -
Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments
por: Audia, Sylvain, et al.
Publicado: (2021)